Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa:: Our worst nightmare?

被引:1022
作者
Livermore, DM [1 ]
机构
[1] Cent Publ Hlth Lab, Antibiot Resistance Monitoring & Reference Lab, London NW9 5HT, England
关键词
D O I
10.1086/338782
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Pseudomonas aeruginosa carries multiresistance plasmids less often than does Klebsiella pneumoniae, develops mutational resistance to cephalosporins less readily than Enterobacter species, and has less inherent resistance than Stenotrophomonas maltophilia. What nevertheless makes P. aeruginosa uniquely problematic is a combination of the following: the species' inherent resistance to many drug classes; its ability to acquire resistance, via mutations, to all relevant treatments; its high and increasing rates of resistance locally; and its frequent role in serious infections. A few isolates of P. aeruginosa are resistant to all reliable antibiotics, and this problem seems likely to grow with the emergence of integrins that carry gene cassettes encoding both carbapenemases and amikacin acetyltransferases.
引用
收藏
页码:634 / 640
页数:7
相关论文
共 29 条
  • [1] A NOVEL INTEGRON-LIKE ELEMENT CARRYING THE METALLO-BETA-LACTAMASE GENE BLA(IMP)
    ARAKAWA, Y
    MURAKAMI, M
    SUZUKI, K
    ITO, H
    WACHAROTAYANKUN, R
    OHSUKA, S
    KATO, N
    OHTA, M
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (07) : 1612 - 1615
  • [2] PROPERTIES OF THE LARGE ION-PERMEABLE PORES FORMED FROM PROTEIN-F OF PSEUDOMONAS-AERUGINOSA IN LIPID BILAYER-MEMBRANES
    BENZ, R
    HANCOCK, REW
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1981, 646 (02) : 298 - 308
  • [3] Emergence of antibiotic-resistant Pseudomonas aeruginosa:: Comparison of risks associated with different antipseudomonal agents
    Carmeli, Y
    Troillet, N
    Eliopoulos, GM
    Samore, MH
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (06) : 1379 - 1382
  • [4] OXA-17, a further extended-spectrum variant of OXA-10 β-lactamase, isolated from Pseudomonas aeruginosa
    Danel, F
    Hall, LMC
    Duke, B
    Gur, D
    Livermore, DM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (06) : 1362 - 1366
  • [5] Nosocomial outbreak of carbapenem-resistant Pseudomonas aeruginosa with a new blaIMP allele, blaIMP-7
    Gibb, AP
    Tribuddharat, C
    Moore, RA
    Louie, TJ
    Krulicki, W
    Livermore, DM
    Palepou, MFI
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (01) : 255 - 258
  • [6] Inhibition of IMP-1 metallo-β-lactamase and sensitization of TMP-1-producing bacteria by thioester derivatives
    Hammond, GG
    Huber, JL
    Greenlee, ML
    Laub, JB
    Young, K
    Silver, LL
    Balkovec, JM
    Pryor, KD
    Wu, JK
    Leiting, B
    Pompliano, DL
    Toney, JH
    [J]. FEMS MICROBIOLOGY LETTERS, 1999, 179 (02) : 289 - 296
  • [7] Antimicrobial susceptibility of Pseudomonas aeruginosa:: results of a UK survey and evaluation of the British Society for Antimicrobial Chemotherapy disc susceptibility test
    Henwood, CJ
    Livermore, DM
    James, D
    Warner, M
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 (06) : 789 - 799
  • [8] Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: Evaluation of a national postmarketing surveillance program
    Itokazu, GS
    Quinn, JP
    BellDixon, C
    Kahan, FM
    Weinstein, RA
    [J]. CLINICAL INFECTIOUS DISEASES, 1996, 23 (04) : 779 - 784
  • [9] Mechanisms of quinolone resistance in clinical strains of Pseudomonas aeruginosa
    Jalal, S
    Wretlind, B
    [J]. MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 1998, 4 (04): : 257 - 261
  • [10] Cloning and characterization of blaVIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate
    Lauretti, L
    Riccio, ML
    Mazzariol, A
    Cornaglia, G
    Amicosante, G
    Fontana, R
    Rossolini, GM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (07) : 1584 - 1590